Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma
Abstract Background Diagnosing pancreatic ductal adenocarcinoma (PDAC) in the setting of metastasis with an unknown primary remains very challenging due to the lack of specific biomarkers. HNF-1B has been characterized as an important transcription factor for pancreatic development and was reported...
Saved in:
Main Authors: | Michelle X. Yang (Author), Ryan F. Coates (Author), Abiy Ambaye (Author), Juli-Anne Gardner (Author), Richard Zubarick (Author), Yuan Gao (Author), Joan Skelly (Author), James G. Liu (Author), Mari Mino-Kenudson (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping
by: Jia Rao, et al.
Published: (2024) -
Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021) -
Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016) -
Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
by: Alexander G. Raufi, et al.
Published: (2021) -
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021)